Most patients with RA produce autoantibodies (rheumatoid factor (RF) and anti-citrullinated protein antibody (ACPA)), which are associated with risk of developing RA and can predict severe disease [1]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.